sulfamic acid has been researched along with Neurofibromatosis 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arellano-Garcia, C; Barald, KF; Chernoff, J; Dohle, W; Jewett, EM; Karchugina, S; Menjivar, RE; Potter, BVL; Shen, YC | 1 |
1 other study(ies) available for sulfamic acid and Neurofibromatosis 2
| Article | Year |
|---|---|
Nonsteroidal sulfamate derivatives as new therapeutic approaches for Neurofibromatosis 2 (NF2).
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Humans; Neurofibromatosis 1; Neurofibromatosis 2; Sulfonic Acids; Wound Healing | 2019 |